OrbiMed Genesis GP LLC, 10% Owner at PMV Pharmaceuticals, Inc. (PMVP), sold 175,572 shares at $2.23 ($392K) on 2023-11-22, disclosed to the SEC on 2023-11-24.
Open-market sale of $392k PMVP by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.23 | 87,786 | $196K | 50.0% |
| 2 | $2.23 | 87,786 | $196K | 50.0% |
| Total | $2.23 avg | 175,572 | $392K | 100% |
| Filing → |
| MBX | BUY | 2025-02-19 | $2.7M | — | Filing → |
| KROS | SELL | 2024-08-15 | $11.0M | — | Filing → |
| TERN | SELL | 2024-07-17 | $562K | — | Filing → |